| Ms Cathy M Sukowaty, APNP, MSN, BSN | |
|
1111 Bayshore Dr, Manitowoc, WI 54220-5548 | |
| (920) 682-6376 | |
| (920) 652-0115 |
| Full Name | Ms Cathy M Sukowaty |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1111 Bayshore Dr, Manitowoc, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336209402 | NPI | - | NPPES |
| 43861300 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 1120-033 (Wisconsin) | Secondary |
| 363L00000X | Nurse Practitioner | 1120 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Cathy M Sukowaty, APNP, MSN, BSN 1035 Kepler Dr, Green Bay, WI 54311-8320 Ph: () - | Ms Cathy M Sukowaty, APNP, MSN, BSN 1111 Bayshore Dr, Manitowoc, WI 54220-5548 Ph: (920) 682-6376 |
News Archive
In recognition of World Immunization Week, which began April 21, the WHO "is calling on nations to help immunize more children against preventable diseases so more lives can be saved," VOA News reports, noting the U.N. health agency "estimates immunization saves the lives of two to three million children every year."
SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1/2 clinical trial of SAGE-547, a neuroactive steroid, in super-refractory status epilepticus (SRSE), a critical condition in which the brain is in a state of persistent seizure.
The Catalysis Foundation for Health (Catalysis), a 501 (c) (3) non-profit entity dedicated to developing sustainable diagnostics for the developing world, announced today that it has received a $5 million grant from the Bill & Melinda Gates Foundation. The grant money will be used to discover new tuberculosis (TB) biomarkers that can be used to improve diagnostic tests and potentially develop more effective TB treatments.
The National Institute on Drug Abuse has awarded a $2.1 million contract to Perlegen Sciences, Inc., to investigate the human genome for DNA variations and candidate genes associated with nicotine addiction.
Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation (AF) and manufacturer of the Cardima Surgical Ablation System, today announced that it has received CE Mark approval with an Indication for the Surgical Treatment of Atrial Fibrillation for its Surgical Ablation Probe. All components of the Cardima Surgical Ablation System are now approved for marketing for the treatment of AF in European countries recognizing CE Mark approval.
› Verified 9 days ago
Barbara J Backus, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-4500 Fax: 920-682-9378 | |
Jessica L Lietzan, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-2436 | |
Veronica Mcfarlane, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1650 S 41st St, Manitowoc, WI 54220 Phone: 920-320-2436 | |
Brenda Stallbaum, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 339 Reed Ave, Manitowoc, WI 54220 Phone: 920-320-8600 | |
Angela R Vandewettering, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1111 Bayshore Dr, Manitowoc, WI 54220 Phone: 920-682-6376 | |
Andrew Allen Malkowski, APNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 926 S 8th St, Manitowoc, WI 54220 Phone: 920-683-4230 Fax: 920-683-4902 | |
Nicole Amber Meissner, AGNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2409 S Alverno Rd, Manitowoc, WI 54220 Phone: 920-901-4420 Fax: 920-682-4243 |